Market Cap 128.77B
Revenue (ttm) 50.27B
Net Income (ttm) 5.84B
EPS (ttm) N/A
PE Ratio 11.17
Forward PE 10.83
Profit Margin 11.63%
Debt to Equity Ratio 0.00
Volume 2,426,200
Avg Vol 2,407,412
Day's Range N/A - N/A
Shares Out 2.54B
Stochastic %K 90%
Beta 0.57
Analysts Strong Sell
Price Target $64.50

Latest News on SNY

Why Are Teva And Sanofi Stocks Trading Higher On Tuesday?

Dec 17, 2024, 9:16 AM EST - 4 weeks ago

Why Are Teva And Sanofi Stocks Trading Higher On Tuesday?

TEVA


Teva, Sanofi say drug to treat IBD met primary targets

Dec 17, 2024, 7:35 AM EST - 4 weeks ago

Teva, Sanofi say drug to treat IBD met primary targets

TEVA


Sanofi plans to change hospital drug-discount program, WSJ reports

Nov 22, 2024, 12:32 PM EST - 2 months ago

Sanofi plans to change hospital drug-discount program, WSJ reports


SandboxAQ CEO on the firm's partnership with Sanofi

Nov 5, 2024, 3:27 AM EST - 2 months ago

SandboxAQ CEO on the firm's partnership with Sanofi


Sanofi Cancels Consumer Healthcare Business Spin-Off

Oct 30, 2024, 2:28 PM EDT - 2 months ago

Sanofi Cancels Consumer Healthcare Business Spin-Off


Sanofi (SNY) Q3 2024 Earnings Call Transcript

Oct 25, 2024, 1:36 PM EDT - 3 months ago

Sanofi (SNY) Q3 2024 Earnings Call Transcript


Sanofi Earnings Boosted by Early Vaccine Sales

Oct 25, 2024, 5:44 AM EDT - 3 months ago

Sanofi Earnings Boosted by Early Vaccine Sales


Sanofi Q3 earnings beat market view, boosted by vaccine sales

Oct 25, 2024, 1:32 AM EDT - 3 months ago

Sanofi Q3 earnings beat market view, boosted by vaccine sales


Sanofi enters exclusive talks with CD&R for Opella sale

Oct 21, 2024, 1:33 AM EDT - 3 months ago

Sanofi enters exclusive talks with CD&R for Opella sale